Changes to the Composition of the Lonza Board
14 February 2026
No Comments
Sami Atiya is nominated to the Lonza Board for his deep experience in healthcare,
Tag: Lonza
Lonza Delivers Strong Profitable Growth in Full-Year 2025 and Successfully Completes Vacaville Site Integration
28 January 2026
No Comments
In 2025, Lonza1 delivered sales of CHF 6.5 billion with +21.7% CER2 growth, and a CORE
Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH)
9 October 2025
No Comments
New aseptic state-of-the-art filling line in Stein (CH) designed for biologics and highly potent
Ethris and Lonza Collaborate to Develop Room-Temperature Stable, Spray-Dried mRNA Vaccines
12 May 2025
No Comments
Ethris, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), have announced a collaboration to..